Stocks Intuitive Surgical Inc

More

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • graphic_word_ofthe_street.jpg

    Stocks ended higher Tuesday, snapping a three-day losing streak, after strong earnings from Merck and a better-than-expected housing report lifted sentiment on the Street.

  • Intuitive Surgical has rallied more than $20 in the last five sessions since we cited unusual buying of stock and options in the company. The sharp rise has taken place amid persistant takeover rumors involving Johnson & Johnson and the robotic surgery giant.

  • Intuitive Surgical, a California company that makes endoscopic instruments, is running higher along with heavy options activity amid takeover rumors.

  • Cramer makes the call on viewers' favorite stocks.

  • Despite of the Dow crossing over 9,000 on Tuesday, the markets all settled down about 4% or greater for the week. Crude oil dipped below $40 per barrel for the first time in 2009 following the weak jobs report.

  • Following are the day’s biggest winners and losers. Find out why shares of Sears and Gamestop popped while Saks and Abercrombie & Fitch dropped.

  • Stocks ended mixed as dismal December retail sales — notably from discount giant Wal-Mart — offset strength in techs, led by Microsoft.

  • Stocks took a hit from weak December retail sales — even from some of the biggest discount names — but trimmed losses arround midday as strength from Microsoft helped push the Nasdaq into positive territory.

  • Weaker-than-expected December numbers from Wal-Mart sent stock futures sharply lower as retailers overall painted a bleak picture of holiday sales.

  • intuitive_surgical.jpg

    Within about a 12-hour period, two healthcare companies have blamed the pullback in hospital spending for worse-than-anticipated financial results.

  • Cramer makes the call on viewers' favorite stocks.

  • Cramer makes the call on viewers' favorite stocks.

  • Students behind the school's investment funds pitch their stocks to the Mad Money host.

  • To give investors an edge, CNBC asked the experts for their best trades now.

  • How to play lower oil prices and a stronger dollar? Jason Trennert of Strategas Research Partners and Doug Mackay of Broadleaf Partners offered their revised sector and stock picks.

  • In the last month healthcare has emerged as the best performing sector in the S&P. Are drug makers a cure for your portfolio in this economic downturn?

  • Following are the day’s biggest winners and losers. Find out why shares of Hershey and Pepsi popped while Boeing and Ryder dropped.

  • Traders work on the floor of the New York Stock Exchange.

    The week was a mixed bag of economic and market news, most of it on the negative side.  Oil prices continued to hit record highs, the market officially entered bear territory and the European Central Bank socked it to the U.S. by raising rates a quarter-point.  Despite all of this, CNBC guests found bright spots in steel, financials, tech and international stocks.

  • To give investors an edge in a holiday-shortened week of trading, CNBC asked the experts for their best trades now.